(Q33762350)

English

Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

object named as

G Velho

12

0 references

Frédéric Fumeron

object named as

F Fumeron

9

0 references

object named as

M Marre

11

0 references

author name string

N Cheurfa

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

G M Brenner

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A F Reis

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

D Dubois-Laforgue

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

R Roussel

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Tichet

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

O Lantieri

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

B Balkau

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Timsit

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

3 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

554-562

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Endoplasmic reticulum stress signaling in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Common variants in WFS1 confer risk of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Clinical risk factors, DNA variants, and the development of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Variation in FTO contributes to childhood obesity and severe adult obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

A genome-wide association study identifies novel risk loci for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Use and abuse of HOMA modeling

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Detailed investigation of the role of common and low-frequency WFS1 variants in type 2 diabetes risk

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

The role for endoplasmic reticulum stress in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

The incretin system and its role in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

The Non–Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR) Study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-010-1989-0

21 January 2018

Diabetes mellitus, diabetes insipidus, and optic atrophy. An autosomal recessive syndrome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21127832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome]

1 reference

https://pubmed.ncbi.nlm.nih.gov/21127832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21127832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress

1 reference

https://pubmed.ncbi.nlm.nih.gov/21127832

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-010-1989-0

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33762350&oldid=2195754049"